Genetics of haemostasis

Haemophilia

Volumn 18, Issue SUPPL.4, 2012, Pages 73-80

  Goodeve, A C ^a   Perry, D J ^b,c   Cumming, T ^b   Hill, M ^b   Jennings, I ^b   Kitchen, S ^b   Walker, I ^b   Gray, E ^d   Jayandharan, G R ^e   Tuddenham, E ^f  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UK NEQAS for Blood Coagulation   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^e CHRISTIAN MEDICAL COLLEGE   (India)

^f ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Bleeding disorders; Genetic diagnosis; Haemophilia; Mutation; Mutational analysis; Quality assurance

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; COMPLEMENTARY DNA; FIBRINOGEN; GENOMIC DNA; PROTHROMBIN;

ACCREDITATION; ARTICLE; BERNARD SOULIER DISEASE; BLEEDING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; CLINICAL LABORATORY; COMPUTER PROGRAM; DNA SEQUENCE; EUROPE; FIBRINOGEN DEFECT; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC DISORDER; GLANZMANN DISEASE; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HISTORY OF MEDICINE; HUMAN; INFORMATION SYSTEM; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STANDARDIZATION; THROMBOCYTE DISORDER; UNITED KINGDOM; VON WILLEBRAND DISEASE; WISKOTT ALDRICH SYNDROME;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; HEMOSTASIS; HUMANS; MOLECULAR BIOLOGY; SEQUENCE ANALYSIS, DNA;

EID: 84862857551     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2012.02832.x     Document Type: Article

References (45)

1. Peyvandi F, Jayandharan G, Chandy M et al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 2006; 12(Suppl. 3): 82-9.
2. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
3. Gitschier J, Wood WI, Goralka TM et al. Characterization of the human factor VIII gene. Nature 1984; 312: 326-30.
4. Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985; 24: 3736-50.
5. Drayna D, White R. The genetic linkage map of the human X chromosome. Science 1985; 230: 753-8.
6. Peake IR, Lillicrap DP, Boulyjenkov V et al. Haemophilia: strategies for carrier detection and prenatal diagnosis. Bull World Health Organ 1993; 71: 429-58.
7. Peyvandi F. Carrier detection and prenatal diagnosis of hemophilia in developing countries. Semin J Thromb Haemost 2005; 31: 544-54.
8. Harper K, Winter RM, Pembrey ME, Hartley D, Davies KE, Tuddenham EGD. A clinically useful DNA probe closely linked to haemophilia A. Lancet 1984; ii: 6-8.
9. Vehar GA, Keyt B, Eaton D et al. Structure of human factor VIII. Nature 1984; 312: 337-42.
10. Wood WI, Capon DJ, Simonsen CC et al. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-7.
11. Gitschier J, Drayna D, Tuddenham EGD, White RL, Lawn RM. Genetic mapping and diagnosis of haemophilia A achieved through a Bcl I polymorphism in the factor VIII gene. Nature 1985; 314: 738-40.
12. Gitschier J, Lawn RM, Rotblat F, Goldman E, Tuddenham EGD. Antenatal diagnosis and carrier detection of haemophilia A using a factor VIII gene probe. Lancet 1985; i: 1093.
13. Wion K, Tuddenham E, Lawn R. A new polymorphism in the factor VIII gene for prenatal diagnosis of haemophilia A. Nucl Acids Res 1986; 14: 4535.
14. Lalloz MRA, McVey JH, Pattinson JK, Tuddenham EGD. Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene. Lancet 1991; 338: 207-11.
15. Lalloz MRA, Schwaab R, McVey JH, Michaelides K, Tuddenham EGD. Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene. Br J Haematol 1994; 86: 804-9.
16. Antonarakis SE, Kazazian HH, Gitschier J, Hutter P, de Moerloose P, Morris MA. Molecular etiology of factor VIII deficiency in hemophilia A. Adv Exp Med Biol 1995; 386: 19-34.
17. Kogan S, Gitschier J. Mutations and a polymorphism in the factor VIII gene discovered by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 1990; 87:2092-6.
18. Lakich D, Kazazian HH Jr, Antonarakis SE, Gitschier J. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 1993; 5: 236-41.
19. Tuddenham EGD, Cooper DN, Gitschier J. et al. Haemophilia A: database of nu-cleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucl Acids Res 1991; 19: 4821-33.
20. Wacey AI, Kemball-Cook G, Kazazian HH et al. The haemophilia A mutation search test and resource site, home page of the factor VIII mutation database: HAMSTeRS. Nucl Acids Res 1996; 24: 100-2.
21. Schwaab R, Brackmann HH, Seehafer J et al. Haemophilia A: mutation type determines risk of inhibitor formation. J Thromb Haemost 1995; 74: 1402-6.
22. Tsui NB, Kadir RA, Chan KC et al. Noninvasive prenatal diagnosis of hemophilia by microflu-idics digital PCR analysis of maternal plasma DNA. Blood 2011; 117: 3684-91.
23. Lin SY, Su YN, Hung CC et al. Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM. BMC Med Genet 2008; 9: 53.
24. MRC-Holland. MRC-Holland MLPA homepage. Available at: Accessed January 28, 2012.
25. Rafati M, Ravanbod S, Hoseini A et al. Identification of ten large deletions and one duplication in the F8 gene of eleven unrelated Iranian severe haemophilia A families using the multiplex ligation-dependent probe amplification technique. Haemophilia 2011; 17: 705-7.
26. Mohl A, Marschalek R, Masszi T et al. An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary. J Thromb Haemost 2008; 6: 1729-35.
27. Castoldi E, Duckers C, Radu C et al. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma. J Thromb Haemost 2011; 9: 959-68.
28. Castaman G, Giacomelli SH, Mancuso ME et al. Deep intronic variations may cause mild hemophilia A. J Thromb Haemost 2011; 9: 1541-8.
29. HGMD. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Available at: Accessed January 28, 2012.
30. NCBI. dbSNP. Available at: Accessed January 28, 2012.
31. NGRL. SNPCheck. Available at: Accessed January 28, 2012.
32. Hampshire DJ, Burghel GJ, Goudemand J et al. Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort. Haematologica 2010; 95: 2163-5.
33. NIBSC. WHO International Genetic Reference Panel for Haemophilia A, Intron-22 inversion. Available at: Accessed January 28, 2012.
34. EuroGenTest. Best Practice Guidelines for Molecular Genetic Testing. Available at: Accessed January 28, 2012.
35. HGNC. HUGO Gene Nomenclature Committee information homepage. Available at: Accessed January 28, 2012.
36. HGVS. Nomenclature for the description of sequence variations homepage. Available at: Accessed January 28, 2012.
37. Perry DJ, Goodeve A, Hill M, Jennings I, Kitchen S, Walker I. The UK National External Quality Assessment Scheme (UK NEQAS) for molecular genetic testing in haemophilia. J Thromb Haemost 2006; 96: 597-601.
38. UKHCDO. Genetics Working Party. Available at: Accessed January 28, 2012.
39. Dequeker E, Cassiman JJ. Genetic testing and quality control in diagnostic laboratories. Nat Genet 2000; 25: 259-60.
40. Tripodi A, Peyvandi F, Chantarangkul V, Menegatti M, Mannucci PM. Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations--a cause for concern. J Thromb Haemost 2002; 88: 690-1.
41. Mueller CR, Kristoffersson U, Stoppa-Lyonnet D. External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3years. Ann Oncol 2004; 15(Suppl. 1): I14-7.
42. Seneca S, Morris MA, Patton S, Elles R, Sequeiros J. Experience and outcome of 3years of a European EQA scheme for genetic testing of the spinocerebellar ataxias. Eur J Hum Genet 2008; 16: 913-20.
43. Bowen DJ, Keeney S. Unleashing the long-distance PCR for detection of the intron 22 inversion of the factor VIII gene in severe haemophilia A. J Thromb Haemost 2003; 89: 201-2.
44. Rossetti LC, Radic CP, Larripa IB, de Brasi CD. Genotyping the haemophilia inversion hotspot by use of inverse PCR. Clin Chem 2005; 51: 1154-8.
45. WHO International Standard. 1st International Genetic Reference Panel for Haemophilia A, Intron 22 Inversion, Human gDNA. NIBSC code: 08/160. Instructions for use. Available at:. Accessed 5 January 2009.